Infusion=1 Tbs/c BID-TID | Tincture (1:2-1:3)=2-5 ml TID
Parts Used
Aerial Parts
References
Awad R, Arnason JT, Trudeau V, et al. Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): a medicinal plant with anxiolytic properties. Phytomedicine. 2003;10(8):640-649.
Bruseth S and Enge A. [Scullcap--liver damage. Mistletoe hepatitis]. Tidsskr.Nor Laegeforen. 8-10-1992;112(18):2389-2390.
Gafner S, Bergeron C, Batcha LL, et al. Inhibition of [3H]-LSD binding to 5-HT7 receptors by flavonoids from Scutellaria lateriflora. J Nat Prod 2003;66(4):535-537.
Li J, Ding Y, Li XC, et al. Scuteflorins A and B, dihydropyranocoumarins from Scutellaria lateriflora. J Nat.Prod. 2009;72(6):983-987.
Sarris J, Panossian A, Schweitzer I, et al. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 2011;21(12):841-860.
Takeshita K, Saisho Y, Kitamura K, et al. Pneumonitis induced by ou-gon (scullcap). Intern.Med. 2001;40(8):764-768.
Wolfson P and Hoffmann DL. An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med 2003;9(2):74-78.
Code by Peter D'Adamo, ND. Portions of the data used by this program are from the Bountiful Herbs Database. Obviously, this program is not a substitute for the services of a health professional and is not actually designed nor intended to be used to diagnosis, prevent or treat disease.
COPYRIGHT 2018 UB CENTER OF EXCELLENCE IN GENERATIVE MEDICINE
